Header Logo

Connection

Kamyar Kalantar-Zadeh M.D. to Rosuvastatin Calcium

Back to Details
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Rosuvastatin Calcium.
Kamyar Kalantar-Zadeh M.D.
Connection Strength
0.040
Rosuvastatin Calcium
  1. Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial. Am Heart J. 2019 11; 217:72-83.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.